Sumitomo Mitsui Trust Holdings, Inc. Seagen Inc. Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	SELL	$191.51 - $216.16 $504,628 - $569,581	-2,635 Reduced 0.68%	383,687 $81.4 Million
Q2 2023 Jul 31, 2023	SELL	$187.64 - $206.25 $11.4 Million - $12.6 Million	-61,012 Reduced 13.64%	386,322 $74.4 Million
Q1 2023 Apr 27, 2023	SELL	$127.59 - $203.08 $1,148 - $1,827	-9 Reduced -0.0%	447,334 $90.6 Million
Q4 2022 Jan 30, 2023	SELL	$117.37 - $139.17 $1.29 Million - $1.53 Million	-10,975 Reduced 2.39%	447,343 $57.5 Million
Q3 2022 Oct 21, 2022	SELL	$135.27 - $180.11 $211,562 - $281,692	-1,564 Reduced 0.34%	458,318 $62.7 Million
Q2 2022 Jul 26, 2022	BUY	$108.81 - $179.33 $1.26 Million - $2.08 Million	11,604 Added 2.59%	459,882 $81.4 Million
Q1 2022 Apr 27, 2022	SELL	$119.61 - $157.85 $1.96 Million - $2.58 Million	-16,358 Reduced 3.52%	448,278 $64.6 Million
Q4 2021 Feb 02, 2022	BUY	$142.57 - $190.86 $6.49 Million - $8.68 Million	45,499 Added 10.86%	464,636 $71.8 Million
Q3 2021 Oct 25, 2021	SELL	$142.45 - $169.82 $3.29 Million - $3.92 Million	-23,076 Reduced 5.22%	419,137 $71.2 Million
Q2 2021 Aug 02, 2021	SELL	$135.08 - $161.1 $243,144 - $289,980	-1,800 Reduced 0.41%	442,213 $69.8 Million
Q1 2021 Apr 30, 2021	SELL	$137.51 - $190.8 $17.2 Million - $23.8 Million	-124,989 Reduced 21.97%	444,013 $61.7 Million
Q4 2020 Feb 05, 2021	BUY	$164.63 - $211.93 $93.7 Million - $121 Million	569,002 New	569,002 $99.7 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.